Bluejay Diagnostics, Inc. Cost of Revenue
Bluejay Diagnostics, Inc. (BJDX) reported Cost of Revenue of $200.13 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2024-03-28.
Discontinued › Expense Statement
us-gaap:CostOfGoodsAndServicesSold · last filed 2024-03-28
- Bluejay Diagnostics, Inc. cost of goods and services sold for the quarter ending 2022-12-31 was $0.00.
- Bluejay Diagnostics, Inc. cost of goods and services sold for the quarter ending 2022-09-30 was $0.00.
- Bluejay Diagnostics, Inc. cost of goods and services sold for the quarter ending 2022-06-30 was $200.13K.
- Bluejay Diagnostics, Inc. cost of goods and services sold for fiscal 2022 was $200.13K.
| Period end | Cost of Goods and Services Sold 3 month | Cost of Goods and Services Sold 6 month | Cost of Goods and Services Sold 9 month | Cost of Goods and Services Sold 12 month |
|---|---|---|---|---|
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $0.00 derived: sum of 2 quarters · filed 2024-03-28 | $200.13K derived: sum of 3 quarters · filed 2024-03-28 | $200.13K 10-K · filed 2024-03-28 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $200.13K derived: sum of 2 quarters · filed 2023-11-09 | $200.13K 10-Q · filed 2023-11-09 | |
| 2022-06-30 | $200.13K 10-Q · filed 2023-08-14 | $200.13K 10-Q · filed 2023-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |